Taisho Pharmaceutical Holdings

Taisho Pharmaceutical Holdings is a prominent manufacturer of specialty and generic drugs, primarily focused on the production and sale of self-medication products. The company's portfolio includes a variety of well-known items, such as cold medicines, allergy medications, and dietary supplements like the Lipovitan and Pabron series. Operating through two main segments—Self-Medication and Prescription Pharmaceuticals—Taisho derives the majority of its revenue from the Self-Medication segment, catering primarily to external customers in Japan. The company also explores mergers and acquisitions as a strategy to enhance its research, development, manufacturing, and marketing capabilities.

Akira Uehara

Chairman, President and CEO

6 past transactions

Biolinq

Series B in 2021
Biolinq is a digital health platform developer that aims to create a pipeline of biomonitoring solutions. The company's platform includes a skin-applied, minimally invasive electrochemical biosensor that analyzes biomarkers in the interstitial fluid to provide actionable health information while continuously monitoring multiple biomarkers, allowing diabetic patients to monitor their blood glucose levels.

Moodify

Series A in 2021
Moodify transforms the way scents are made to make better, more effective and sustainable consumer products, making the design and manufacturing faster, more scalable, accurate, cost effective and compliant. This, by harnessing 15 years of neuroscience research by the Weizmann Institute, together with cutting edge bioinformatics machine learning technologies.

Aiwell

Series A in 2020
Aiwell is a medical and health company that provides health information and the provision of health promotion and prevention services.

Nanotis

Series A in 2020
Nanotis is a company which Solve various problems in infectious disease tests such as influenza.

Quantum Operation

Corporate Round in 2020
Quantum Operation manufactures and markets IoT sensors for the medical and nursing industries.

UPSA SAS

Acquisition in 2018
UPSA SAS specialists in the fight against pain and self-medication. UPSA SAS offers pharmaceuticals, food supplements, and medical devices for patients ranging from infants to seniors.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.